Home › Endometrial Cancer › Oregon › Beaverton
Endometrial Cancer clinical trials in Beaverton, OR
4 studies for Endometrial Cancer are looking for participants at sites in and around Beaverton (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecruitingPhase 2
- Providence Newberg Medical Center, Newberg · 15 mi away
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
RecruitingPhase 3
- Legacy Meridian Park Hospital, Tualatin · 7 mi away
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
RecruitingPhase 3
- USOR - NW Cancer Specs. P.C., Tigard · 4 mi away
Symbiotic-GYN-18: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Advanced or Recurrent MMR-proficient Endometrial Cancer
RecruitingPhase 3
- Northwest Cancer Specialists, P.C., Tigard · 4 mi away
Endometrial Cancer trials in other cities
- Houston, TX69 studies
- New York City, NY54 studies
- Boston, MA51 studies
- Arlington, VA41 studies
- Nashville, TN38 studies
- Los Angeles, CA35 studies
- St. Louis, MO29 studies
- Philadelphia, PA29 studies
- Oklahoma City, OK28 studies
- San Antonio, TX27 studies
- Queens, NY26 studies
- Dallas, TX25 studies
Other studies in Beaverton
- Non-Small Cell Lung Cancer8 studies
- Lung Cancer8 studies
- Breast Cancer6 studies
- Ovarian Cancer5 studies
- Prostate Cancer5 studies
- Colorectal Cancer5 studies
- Bladder Cancer4 studies
- Cancer (all types)3 studies
- Acute Myeloid Leukemia3 studies
- Kidney Cancer (Renal Cell Carcinoma)3 studies
- Urothelial (Transitional Cell) Carcinoma3 studies
- Diffuse Large B-Cell Lymphoma3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.